Clinical models named as such in the literature (PRED-SURVIVAL)

ECHO (2)
AMI (1)

Circulation. 2002 Jan 15;105(2):200-6.
Predicting death in patients with acute type a aortic dissection.
Mehta RH, Suzuki T, Hagan PG, Bossone E, Gilon D, Llovet A, Maroto LC, Cooper JV, Smith DE, Armstrong WF, Nienaber CA, Eagle KA,
University of Michigan, Ann Arbor 48109, USA.

J Invasive Cardiol. 2002 Oct;14(10):603-8.
Supplemental value of troponin I combined with a clinical risk model to predict in-hospital events in intermediate and high risk patients with acute coronary syndromes.
Merrill B, Calvin JE, Klein LW,
Rush Heart Institute, Rush-Presbyterian-St. Luke s Medical Center, 1653 West Congress Parkway, Suite 1035, Jelke, Chicago, IL, 60612, USA.

Am J Cardiol. 2002 Dec 15;90(12):1284-9.
Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden.
Tsang TS, Barnes ME, Gersh BJ, Bailey KR, Seward JB,
Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA.

Can J Anaesth. 2003 Mar;50(3):305-10.
Transthoracic echocardiography does not improve prediction of outcome over APACHE II in medical-surgical intensive care.
Sawchuk CW, Wong DT, Kavanagh BP, Siu SC,
Medical Surgical Intensive Care Unit, Department of Anesthesia, University Health Network, University of Toronto, Ontario, Canada.

Diabetes Care. 2003 Apr;26(4):1074-8.
Prognostic value of dobutamine stress echocardiography in patients with diabetes.
Sozzi FB, Elhendy A, Roelandt JR, van Domburg RT, Schinkel AF, Vourvouri EC, Bax JJ, De Sutter J, Borghetti A, Poldermans D,
Erasmus Medical Centre, Rotterdam, The Netherlands.

Arch Gerontol Geriatr. 2003 Mar-Apr;36(2):155-71.
Social and medical risk indicators for 8-year mortality in a Swedish urban elderly population.
Augustsson O, Matousek M, Eriksson BG, Rothenberg E, Steen B,
Department of Geriatric Medicine, Goteborg University, Gibraltargatan 1 C, SE 411 32 Goteborg, Sweden.

JAMA. 2003 Nov 19;290(19):2581-7.
Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model.
Lee DS, Austin PC, Rouleau JL, Liu PP, Naimark D, Tu JV,
Department of Health Policy, Management, and Evaluation/Clinical Epidemiology, Division of Cardiology, University Health Network-Toronto General Hospital, Toronto, Ontario.

Int J Radiat Oncol Biol Phys. 2004 Apr 1;58(5):1394-404.
Quality of life as a survival predictor for esophageal squamous cell carcinoma treated with radiotherapy.
Fang FM, Tsai WL, Chiu HC, Kuo WR, Hsiung CY,
Department of Radiation Oncology, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung Hsien, Taiwan.

Presse Med. 2004 Apr 10;33(7):467-73.
[High and low-risk febrile neutropenic patients]
Blot F, Nitenberg G,
Service de reanimation medico-chirurgicale, Institut Gustave Roussy, 39 rue Camille Desmoulins, 94 805 Villejuif, France.

Am J Cardiol. 2004 Sep 15;94(6):733-9.
Prognostic value of dobutamine stress echocardiography in patients with systemic hypertension and known or suspected coronary artery disease.
Sozzi FB, Elhendy A, Rizzello V, van Domburg RT, Kertai M, Vourvouri E, Schinkel AF, Bax JJ, Roelandt JR, Poldermans D,
Thoraxcentre, Erasmus Medical Centre, Dr Molewaterplein 40, 3015 GD Rotterdam, The Netherlands.

J Clin Oncol. 2005 Jan 1;23(1):175-83.
Clinical model to predict survival in chemonaive patients with advanced non-small-cell lung cancer treated with third-generation chemotherapy regimens based on eastern cooperative oncology group data.
Hoang T, Xu R, Schiller JH, Bonomi P, Johnson DH,
University of Wisconsin Medical School, 600 Highland Ave, K4/562, Madison, WI, USA.

Med Care. 2005 Feb;43(2):149-58.
Mortality after cardiac bypass surgery: prediction from administrative versus clinical data.
Geraci JM, Johnson ML, Gordon HS, Petersen NJ, Shroyer AL, Grover FL, Wray NP,
Houston Center for Quality of Care and Utilization Studies, Houston Veterans Affairs Medical Center, and the Section of Health Services Research, Department of Medicine, Baylor College of Medicine, Houston, Texas 77030, USA.

J Urol. 2005 May;173(5):1496-501.
Using tumor markers to predict the survival of patients with metastatic renal cell carcinoma.
Kim HL, Seligson D, Liu X, Janzen N, Bui MH, Yu H, Shi T, Belldegrun AS, Horvath S, Figlin RA,
Department of Urologic Oncology, Roswell Park Cancer Institute, Buffalo, New York, USA.

[Literature] [Home]